More Healthcare Coverage

  • March 27, 2026

    Skincare Co. Says ITC Ruling Backs Ending PTAB Challenge

    Skin products company Hydrafacial has argued U.S. Patent and Trademark Office Director John Squires should turn down a rehearing request from rival Sinclair Pharma over Squires' order de-instituting a challenge to Hydrafacial's patent, saying a U.S. International Trade Commission decision upholding the same patent supports the director's move.

  • March 27, 2026

    States Suspect ICE Obtained Medicaid Data Despite Order

    A coalition of states told a federal judge that the Trump administration appears to have ignored an order limiting the types of Medicaid data that can be shared with immigration officials, potentially handing over reams of "off limits" data on citizens and green card holders.

  • March 27, 2026

    Colo. Nurses Snag Class Cert. In Holiday Pay Case

    A group of nurses can proceed as a class in a suit accusing a healthcare company of excluding holiday premiums from their pay when they worked overtime, a Colorado federal judge has ruled.

  • March 26, 2026

    9th Circ. Upholds Medtronic Win In Spinal Cord Device Suit

    A Washington man cannot sue medical device maker Medtronic USA Inc. on allegations it sold him a spinal cord implant that malfunctioned causing greater pain, the Ninth Circuit ruled, saying he lacked expert witnesses to support his negligence claims.

  • March 26, 2026

    IOC Bans Transgender Athletes From Women's Competitions

    The International Olympic Committee announced a ban Thursday on transgender athletes competing in women's events, a policy shift that will see Olympic hopefuls subjected to genetic testing to determine their eligibility.

  • March 25, 2026

    Ex-Pharma GC Freed From Trade Secrets Suit Amid Ch. 7 Stay

    A Texas federal judge agreed to dismiss claims against the ex-general counsel of a Houston-based pharmaceutical services company, who was accused of helping build a competing venture using confidential information and of destroying a hard drive containing evidence he had a duty to preserve during litigation.

  • March 25, 2026

    McKesson Accuses Former Exec Of Leaking Trade Secrets

    Healthcare services company McKesson Corp. alleged in Colorado federal court that its former senior executive disclosed the company's confidential information and trade secrets to a direct competitor in breach of contract when she left the company to work for the competitor.

  • March 25, 2026

    Mom Tying Abbott Formula To Baby's NEC Takes The Stand

    A plaintiff claiming Abbott Laboratories' preterm baby formula contributed to her infant's development of a serious gut condition told an Illinois jury Wednesday that she wouldn't have allowed her baby to consume the formula had she known it increased the risk of the infection, saying her now-teenage daughter still struggles with medical complications as a result.

  • March 24, 2026

    Immigrant Minors Seek End To Repeat Sponsor Checks

    A youth advocacy attorney nearly came to tears as she told a D.C. federal judge of immigrant children being torn from their parents Tuesday, urging the judge to block a Trump administration policy requiring that previously approved custodians reapply to sponsor "unaccompanied" children while the minors are held in government facilities.

  • March 24, 2026

    Drug Co. Atara Hit With Investor Suit Over FDA Denial

    Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.

  • March 23, 2026

    Md. Judge Rules Written Consent Not Needed Under TCPA

    Echoing a recent Fifth Circuit ruling, a Maryland federal judge has held that written consent to receive telemarketing calls is not required under the Telephone Consumer Protection Act, reversing a decision to certify a class of consumers against a dental plan marketer.

  • March 23, 2026

    Healthcare Co. Liable For Patient's Killings, Philly Jury Told

    A healthcare management company's failure to submit proper paperwork prohibiting a man who was committed to a hospital for psychosis allegedly enabled him to buy the shotgun he used to slay his family, counsel for their estates told a Philadelphia jury Monday.

  • March 20, 2026

    Former Gilead Sciences GC To Earn Over $2.5M Severance

    Gilead Sciences Inc. is paying its former general counsel more than $2.5 million in severance after she left the company, according to a U.S. Securities and Exchange Commission filing released Friday.

  • March 20, 2026

    Eli Lilly Beats 9th Circ. Appeal Over Brain Bleed After Cialis

    A Ninth Circuit panel Friday upheld Eli Lilly and Co.'s win over a Washington man who claimed the company's erectile dysfunction drug Cialis caused bleeding in his brain, ruling David Dearinger failed to establish that doctors would have acted differently had they been warned of the medication's risks.

  • March 19, 2026

    4th Circ. Leery Of W.Va. Opioid Towns' Abatement Arguments

    During a heated hourlong oral argument Thursday, two Fourth Circuit judges interrogated an attorney for West Virginia municipalities stricken by the opioid crisis about whether the public nuisance of overly available drugs had already been abated, leaving only redress of resulting harms.

  • March 19, 2026

    Maya Kowalski Says Atty Made Her 'Uncomfortable'

    The attorney who persuaded a jury to award $261 million to Netflix documentary subject Maya Kowalski also provided unsolicited dating and sex advice to his 18-year-old client and arranged an advance funding loan for the Kowalski family in violation of Florida Bar rules, according to a statement Kowalski filed.

  • March 19, 2026

    Ohio Home Health Co. Settles OT Suit For $975K

    A Columbus-area home health services company will pay $975,000 to end a lawsuit accusing it of misclassifying its program managers as exempt from overtime, according to an Ohio federal court filing.

  • March 18, 2026

    NC Judge Moves Ex-Exec's Wage Fight With Cancer Co. To Va.

    A North Carolina federal judge agreed to transfer a former C-suite executive's unpaid wages case against a Canadian cancer testing and treatment company to Virginia, where its U.S. headquarters are, finding the Old Dominion is the better venue.

  • March 17, 2026

    9th Circ. Says Idaho Doc Must Face Wash. Fatal Overdose Suit

    A Ninth Circuit panel has reversed the dismissal of a suit alleging an Idaho-based doctor overprescribed drugs to a Washington woman, leading to her death, finding that the doctor and her clinic had enough contacts with Washington for a federal district court in that state to have jurisdiction.

  • March 13, 2026

    Cannabis Co. Loses Bid To Merge Rival's Suit With AI Fight

    A Florida federal judge has found "there is no basis to consolidate" two lawsuits between medical marijuana company Leafwell and its competitor My Florida Green, concluding Leafwell's lawsuit accusing My Florida Green's counsel of misusing artificial intelligence to wreck Leafwell's business doesn't substantially overlap with My Florida Green's unfair business practice suit against Leafwell and others.

  • March 13, 2026

    J&J Unit Says Ex-Director Misappropriated Trade Secrets

    A Johnson & Johnson subsidiary has accused a former associate director of downloading over 7,000 files worth of confidential information prior to her resignation and using it to start her own competing company.

  • March 12, 2026

    Idaho Says Director Immune In THC Child Abuse Registry Suit

    The director of Idaho Health and Welfare is asking a federal court to throw out claims from two women alleging the state violated their constitutional rights by putting them on the state's child abuse registry for their use of cannabis while pregnant, saying the director is immune and the state's rules satisfy due process.

  • March 11, 2026

    Eli Lilly Ordered To Arbitrate Alzheimer's Drug Feud

    An Illinois federal judge ordered Eli Lilly and Co. on Tuesday to arbitrate a dispute over millions of dollars in milestone payments allegedly owed under a collaboration agreement to develop an Alzheimer's disease drug, ruling that the drugmaker lacked standing to challenge an underlying security agreement.

  • March 11, 2026

    Pharma Co. Says Ex-Director Using Trade Secrets At New Job

    A specialty infusion therapy pharmacy has accused a former director of contracts of taking valuable trade secrets with her on her way out to work for a rival company.

  • March 11, 2026

    Pa. Justices Hint 3rd Jury Should Decide Misdiagnosis Case 

    The Pennsylvania Supreme Court on Wednesday appeared skeptical of an oncologist's argument that she should not have to face a third trial in a suit accusing her of treating a now-deceased woman for the wrong type of cancer, suggesting that disputed facts about the patient's care make the case suitable for a jury.

Expert Analysis

  • 7 Ways To Fetch Patents In The World Of Working Animals

    Author Photo

    Though developers rarely file patents related to working animals, and animal training techniques are generally considered unpatentable, certain aspects of training and developing animals may be ripe for patent protection, say Matthew Avery at Baker Botts, Makenzi Galvan at Perkins Coie and Lute Yang at Orrick.

  • Law School's Missed Lessons: How To Make A Deal

    Author Photo

    Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable.

  • 4th Circ. Clarifies Employer Duties For ADA Accommodations

    Author Photo

    The Fourth Circuit's recent decision in Tarquinio v. Johns Hopkins indicates that an employer's obligation to provide accommodations under the Americans with Disabilities Act may never arise if an employee obstructs the process, underscoring that ADA protections depend on cooperation between both parties, say attorneys at Hunton.

  • From Clerkship To Law Firm: 5 Transition Tips For Associates

    Excerpt from Practical Guidance
    Author Photo

    Transitioning from a judicial clerkship to an associate position at a law firm may seem daunting, but by using knowledge gained while clerking, being mindful of key differences and taking advantage of professional development opportunities, these attorneys can flourish in private practice, say attorneys at Lowenstein Sandler.

  • Budget Act Should Boost Focus On Trade Compliance

    Author Photo

    Passage of the One Big Beautiful Budget Act, coupled with recent U.S. Department of Justice statements that it will use the False Claims Act aggressively to pursue trade, tariff and customs fraud, marks a sharp increase in trade-related enforcement risk, say attorneys at Debevoise.

  • Associates Can Earn Credibility By Investing In Relationships

    Author Photo

    As the class of 2025 prepares to join law firms this fall, new associates must adapt to office dynamics and establish credible reputations — which require quiet, consistent relationship-building skills as much as legal acumen, says Kyle Forges at Bast Amron.

  • Lessons From 7th Circ.'s Deleted Chat Sanctions Ruling

    Author Photo

    The Seventh Circuit’s recent decision in Pable v. Chicago Transit Authority, affirming the dismissal of an ex-employee’s retaliation claims, highlights the importance of properly handling the preservation of ephemeral messages and clarifies key sanctions issues, says Philip Favro at Favro Law.

  • What 2 Profs Noticed As Transactional Law Students Used AI

    Author Photo

    After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.

  • BigLaw Settlements Should Not Spur Ethics Deregulation

    Author Photo

    A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.

  • 8th Circ. Should Reaffirm False Commercial Speech's Nature

    Author Photo

    The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.

  • 5 Ways Lawyers Can Earn Back The Public's Trust

    Author Photo

    Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.

  • What US-India Trade Deal Will Mean For Indian Pharma

    Author Photo

    Complicated by newly imposed tariffs from the U.S., the outcome of the U.S.-India trade talks is poised to reshape not just trade policy, but also the strategic alignment of the two countries' pharmaceutical ecosystems, says Jashaswi Ghosh at Holon Law Partners.

  • Law School's Missed Lessons: Negotiation Skills

    Author Photo

    I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.